[Banking and indications for cord blood grafts]

Abstract : A cord blood graft is now frequently used in the context of allogeneic hematopoietic transplantation. In 2007, 27% of unrelated allotransplantations performed in France used a cord blood graft. In comparison to other sources of hematopoietic grafts, cord blood has a number of advantages (immediate availability of the graft, possibility of a lesser HLA compatibility between donor and recipient...) and inconveniences (a limited number of stem cells, increased risk of infectious complications...). Recently, the possibility of combining two cord blood grafts has been demonstrated. In 2007, 55% of unrelated cord blood grafts transplantation were performed as such. Results of multicentric studies published as of now, as well as considerable potential associated with cord blood transplantation requires important efforts to increase both the quantity and quality of cord blood grafts made available for transplantation.
Type de document :
Article dans une revue
Transfusion Clinique et Biologique, Elsevier, 2009, 16 (2), pp.204-8. 〈10.1016/j.tracli.2009.03.011〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00484493
Contributeur : Philippe Saas <>
Soumis le : mardi 18 mai 2010 - 15:03:46
Dernière modification le : lundi 9 juillet 2018 - 13:12:02

Identifiants

Collections

Citation

Pierre Tiberghien, Jacqueline Chabod, Eric Deconinck, Fabienne Pouthier. [Banking and indications for cord blood grafts]. Transfusion Clinique et Biologique, Elsevier, 2009, 16 (2), pp.204-8. 〈10.1016/j.tracli.2009.03.011〉. 〈inserm-00484493〉

Partager

Métriques

Consultations de la notice

106